Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.

Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.
复制标题

DOI:
10.1021/acsnano.7b03239
复制
发表时间:
2017-10-24
期刊:
影响因子:
17.1
通讯作者:
Neish AS
Neish AS
中科院分区:
材料科学1区
文献类型:
--
作者:
Herrera Estrada L;Wu H;Ling K;Zhang G;Sumagin R;Parkos CA;Jones RM;Champion JA;Neish AS

文献摘要

参考文献

被引文献

相似文献

细菌肠道病原体已经进化出有效的机制来抑制哺乳动物的炎症和免疫调节途径。通过利用肠道和病原菌之间的进化关系,我们开发出了一种潜在的粘膜治疗剂。我们的研究结果表明,沙门氏菌乙酰转移酶 AvrA 的工程制剂可以抑制急性炎症反应,例如在炎症性肠病 (IBD) 中观察到的炎症反应。我们直接从 AvrA 和载体蛋白创建了直径 125 nm 的交联蛋白纳米粒子,以便在没有沙门氏菌的情况下递送 AvrA。 AvrA 纳米粒子在体外和体内内化到屏障上皮和固有层单核细胞中。 AvrA 纳米颗粒在体外抑制炎症信号传导并赋予细胞保护作用,在小鼠结肠炎模型中,我们观察到炎症的临床和组织学指数降低。因此,我们将自然进化的免疫调节蛋白与现代生物工程相结合,生产出 AvrA 纳米颗粒,这是 IBD 的一种潜在治疗方法。
Bacterial enteric pathogens have evolved efficient mechanisms to suppress mammalian inflammatory and immunoregulatory pathways. By exploiting the evolutionary relationship between the gut and pathogenic bacteria, we have developed a potential mucosal therapeutic. Our findings suggest that engineered preparations of the Salmonella acetyltransferase, AvrA, suppress acute inflammatory responses such as those observed in inflammatory bowel disease (IBD). We created 125 nm diameter cross-linked protein nanoparticles directly from AvrA and carrier protein to deliver AvrA in the absence of Salmonella. AvrA nanoparticles are internalized in vitro and in vivo into barrier epithelial and lamina propria monocytic cells. AvrA nanoparticles inhibit inflammatory signaling and confer cytoprotection in vitro, and in murine colitis models, we observe decreased clinical and histological indices of inflammation. Thus, we have combined naturally evolved immunomodulatory proteins with modern bioengineering to produce AvrA nanoparticles, a potential treatment for IBD.
DOI: 10.1016/j.addr.2008.11.002
发表时间: 2009-02-27
影响因子: 16.1
作者:
Lai, Samuel K.;Wang, Ying-Ying;Hanes, Justin
通讯作者: Hanes, Justin
DOI: 10.1038/mi.2013.84
发表时间: 2014-05
期刊: Mucosal immunology
影响因子: 8
作者:
通讯作者: --
制备基于聚合物的缓释系统,无需将蛋白质暴露于水-油或水-空气界面和交联试剂
DOI: 10.1016/j.jconrel.2008.02.010
发表时间: 2008-05-22
影响因子: 10.8
作者:
Jin, Tuo;Zhu, Hahao;Zhu, Hua
通讯作者: Zhu, Hua
谷胱甘肽响应纳米载体作为靶向细胞内药物和基因递送的有前途的平台
DOI: 10.1016/j.jconrel.2011.01.030
发表时间: 2011-05-30
影响因子: 10.8
作者:
Cheng, Ru;Feng, Fang;Zhong, Zhiyuan
通讯作者: Zhong, Zhiyuan
细菌效应器设计和功能的常见主题。
DOI: 10.1016/j.chom.2009.04.008
发表时间: 2009-06-18
影响因子: 30.3
作者:
Galan, Jorge E.
通讯作者: Galan, Jorge E.